Advertisement
Screener

AYTU BIOPHARMA, INC (AYTU) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

AYTU BIOPHARMA, INC Cash Flow Breakdown

Cash flow breakdown shows where AYTU BIOPHARMA, INC's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2026-06-30: from running the business, $3.28M came in.
  • Fiscal year ended 2026-06-30: from investing, $29.00K went out.
  • Fiscal year ended 2026-06-30: from financing, $7.90M went out.
  • Fiscal year ended 2026-06-30: change in cash, $4.64M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtCommercial paperNew shares soldOtherNot split outChange in cash
2026-06-30$3.28M-$29.00K-$1.86M$0.00-$6.04M*-$4.64M
2025-06-30-$1.94M-$2.56M-$1.86M$1.86M$15.44M*$10.95M
2024-06-30-$1.39M-$329.00K-$15.72M$13.00M$1.46M*-$2.98M
2023-06-30-$5.13M-$117.00K-$96.00K$15.57M-$6.61M*$3.63M
2022-06-30-$28.82M-$3.25M-$4.12M*$11.69M-$7.00K-$6.04M*-$30.54M
2021-06-30-$25.96M-$2.78M-$2.77M*$45.05M-$5.00K-$11.96M*$1.57M
2020-06-30-$28.37M-$5.66M$640.00K$65.73M$0.00$4.70M*$37.04M
2019-06-30-$13.83M-$1.06M$0.00$19.08M*$4.18M
2018-06-30-$15.94M-$484.29K$0.00$22.66M*$6.23M
2017-06-30-$13.83M-$3.53M$739.86K$9.45M*-$7.18M
2016-06-30-$10.66M-$5.30M$0.00$16.66M*$701.13K
2015-06-30-$6.63M-$1.00M$0.00$12.35M*$4.71M
2014-06-30-$5.50M-$9.30K$5.24M*-$274.05K
2013-08-31-$37.70K$0.00*$5.00K
2012-08-31-$37.85K$0.00*$18.21K
2011-08-31-$64.82K$43.50K

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtCommercial paperNew shares soldOtherNot split outChange in cash
2026-06-30$4.41M*-$12.00K*-$464.00K*-$4.34M*
2026-03-31-$4.18M*$0.00*-$464.00K*$1.34M*
2025-12-31$3.67M*-$17.00K*-$465.00K*-$5.80M*
2025-09-30-$618.00K$0.00-$464.00K$2.76M*$1.68M
2025-06-30$2.80M*-$3.02M*-$464.00K*$13.46M*
2025-03-31-$6.46M*-$69.00K*-$464.00K*$4.76M*
2024-12-31$2.90M*$145.00K*-$465.00K*-$2.29M*
2024-09-30-$1.19M$381.00K-$464.00K$1.38M*$102.00K
2024-06-30-$788.00K*-$34.00K*-$15.65M*$16.72M*
2024-03-31-$254.00K*-$45.00K*-$25.00K*$555.00K*
2023-12-31-$135.00K*-$174.00K*
2023-09-30-$211.00K-$76.00K-$2.73M*-$3.02M
2023-06-30$9.37M*-$155.00K*-$23.00K*-$5.38M*
2023-03-31-$2.91M*$1.00K*-$73.00K*$2.97M*
2022-12-31-$2.44M*-$5.00K*-$51.00K*-$1.81M*
2022-09-30-$9.15M$42.00K$4.27M*-$13.00K$9.30M*$4.45M
2022-06-30-$7.09M*-$41.00K*$428.00K-$1.01M*$0.00*
2022-03-31-$9.12M*-$70.00K*-$3.77M*$7.88M*-$1.00K*-$2.58M*
2021-12-31-$8.82M*-$3.05M*$4.52M*$0.00*$2.07M*
2021-09-30-$3.79M-$86.00K-$3.41M*-$6.00K-$2.04M*-$9.34M
2021-06-30-$6.28M*-$2.43M*-$48.01M*$12.80M*$47.02M*
2021-03-31$19.70M-$317.00K*$0.00*-$6.40M*
2020-12-31-$2.92M*-$30.00K*$29.60M-$2.52M*
2020-09-30-$7.98M-$9.00K-$2.18M*-$10.17M
2020-06-30-$7.76M*-$45.27K*$0.00*-$6.37M*-$14.18M*
2020-03-31$20.60M$343.90K*$640.00K*$67.54M*$57.01M*
2019-12-31-$6.10M*-$4.91M*$9.26M*-$1.75M*
2019-09-30-$2.99M-$1.04M-$4.03M
2019-06-30-$3.47M*-$96.11K*-$5.00M*-$3.45M*
2019-03-31-$3.31M*-$105.59K*$0.00*-$3.16M*
2018-12-31-$4.30M*-$557.11K*$18.70M*$13.84M*
2018-09-30-$2.74M-$303.18K-$3.05M
2018-06-30-$4.54M*-$402.20K*$0.00*-$4.97M*
2018-03-31-$4.08M*-$69.90K*$0.00*$12.25M*$8.10M*
2017-12-31-$3.10M*-$3.11M*
2017-09-30-$4.22M$10.44M*$6.22M
2017-06-30-$3.27M*$539.05K*$108.38K*-$2.67M*
2017-03-31-$2.39M*-$1.28M*$0.00*$1.91M*-$1.76M*
2016-12-31-$2.84M*-$2.29M*$0.00*$7.61M*$2.48M*
2016-09-30-$5.33M-$504.72K$631.48K-$5.23M
2016-06-30-$2.66M*-$4.56M*$0.00*$6.62M*-$611.64K*
2016-03-31-$2.39M*-$78.42K*$0.00*-$2.29M*
2015-12-31-$3.45M*-$659.61K*$0.00*$5.00M*$890.52K*
2015-09-30-$2.16M-$3.55K$0.00$4.88M*$2.72M
2015-06-30-$1.79M*-$1.00M*$8.65M*$5.86M*
2015-03-31-$1.27M*$0.00*$2.60M*$1.33M*
2015-02-28-$13.40K*$0.00*
2014-12-31-$1.39M*$500.00K*-$890.67K*
2014-11-30-$9.33K$15.00K
2014-09-30-$2.19M$600.00K*-$1.59M
2014-06-30-$1.77M*-$1.48M*
2014-05-31-$14.41K*$0.00*$17.70K*
2014-02-28-$8.34K*$0.00*$0.00*
2013-11-30-$6.86K$0.00*$3.00K*
2013-08-31-$5.23K*$0.00*$0.00*
2013-05-31-$15.27K*$0.00*$0.00*
2013-02-28-$8.28K*$0.00*$0.00*
2012-11-30-$8.92K$0.00*$5.00K
2012-08-31-$12.56K*$0.00*$0.00*
2012-05-31-$5.91K*$0.00*$4.72K*
2012-02-29-$8.37K*$0.00*$7.50K*
2011-11-30-$11.01K$0.00$5.99K
2011-08-31-$9.30K*$12.50K*
2011-05-31-$17.50K*$6.00K*
2011-02-28-$26.13K*$20.00K*
2010-11-30-$11.88K$0.00$5.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
NextCure, Inc. (NXTC)United States$0.024B-0.15
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
ARTELO BIOSCIENCES, INC. (ARTL)United States$0.023B
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
Cocrystal Pharma, Inc. (COCP)United States$0.022B
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77